Study Title and Description
Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.|
|Author||Lo A., Egidi MF., Gaber LW., Shokouh-Amiri MH., Nazakatgoo N., Fisher JS., Gaber AO.|
|Country||Departments of a Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.|
Pubmed ID: 15108771
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.